Envoy Medical, Inc. COCH · Stock Open Envoy Medical, Inc. in new tab
Analyst price targets
Recent rating changes, newest first
Envoy Medical, Inc. Analysis (COCH)
Is Envoy Medical, Inc. a good investment? Envoy Medical, Inc. (COCH) is currently trading at 7.12 USD. Market analysts have a consensus price target of 21.67 USD. This suggests a potential upside from current levels.
Earnings Schedule: Envoy Medical, Inc. is expected to release its next earnings report on Nov. 9, 2026. The market consensus estimate for Forward EPS is -2.35.
Investor FAQ
Does Envoy Medical, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Envoy Medical, Inc.?
Envoy Medical, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 9, 2026. The company currently has a trailing EPS of -7.55.
Company Profile
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 26, 2026 | 1:10 |
Community Discussion